Triglycerides :: chemical structure, biosynthesis and role in disease /
In this book, the authors discuss the chemical structure, biosynthesis and role in disease of triglycerides. Topics include lipid levels in neuropsychiatric disorders; the role of circadian clocks in the absorption and metabolism of dietary triglycerides; serum lipoprotein lipase mass as a novel bio...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Biomedical,
[2013]
|
| Schriftenreihe: | Endocrinology research and clinical developments.
Biochemistry research trends series. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | In this book, the authors discuss the chemical structure, biosynthesis and role in disease of triglycerides. Topics include lipid levels in neuropsychiatric disorders; the role of circadian clocks in the absorption and metabolism of dietary triglycerides; serum lipoprotein lipase mass as a novel biomarker of insulin sensitivity; and the effect of plasma lipids and APOE genotype on cognitive decline. |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781624177286 162417728X |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn846915995 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 121205s2013 nyua ob 001 0 eng | ||
| 010 | |a 2019713992 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d YDXCP |d COO |d EBLCP |d DEBSZ |d AGLDB |d OCLCF |d VTS |d CEF |d AU@ |d STF |d M8D |d N$T |d OCLCO |d E7B |d CNSPO |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 015 | |a GBB350009 |2 bnb | ||
| 016 | 7 | |a 016416269 |2 Uk | |
| 019 | |a 847619635 | ||
| 020 | |a 9781624177286 |q (ebook) | ||
| 020 | |a 162417728X | ||
| 020 | |z 1624177271 |q (hbk.) | ||
| 020 | |z 9781624177279 |q (hbk.) | ||
| 035 | |a (OCoLC)846915995 |z (OCoLC)847619635 | ||
| 050 | 0 | 0 | |a QP752.T74 |
| 060 | 4 | |a QU 85 | |
| 072 | 7 | |a MED |x 060000 |2 bisacsh | |
| 082 | 7 | |a 612.397 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Triglycerides : |b chemical structure, biosynthesis and role in disease / |c Calista Araujo and Demetrio Perez, editors. |
| 264 | 1 | |a New York : |b Nova Biomedical, |c [2013] | |
| 264 | 4 | |c ©2013 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Endocrinology, research and clinical developments | |
| 490 | 1 | |a Biochemistry research trends | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a TRIGLYCERIDES ; TRIGLYCERIDES ; CONTENTS ; PREFACE ; LIPID LEVELS IN NEUROPSYCHIATRIC DISORDERS; ABSTRACT ; 1. LIPIDS AND THE CENTRAL NERVOUS SYSTEM ; 2. LIPIDS IN ALZHEIMER'S DISEASE ; 2.1. Subjects and Methods; Subjects ; Methods ; Statistical Analysis ; 2.2. Results ; 3. LIPIDS AND MOOD DISORDERS ; 3.1. Lipid Levels in Affective Disorders ; 3.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.1.2. Results ; 3.2. Lipid Levels in Psychotic Mania ; 3.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.2.2. Results. | |
| 505 | 8 | |a 4. LIPIDS AND SUICIDAL BEHAVIOR 4.1. Lipid Levels and Suicidal Behavior in Borderline Personality Disorder ; 4.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.1.2. Results ; 4.2. Lipid Levels and Suicidal Behavior in Psychotic Disorder ; 4.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.2.2. Results ; 5. LIPIDS AND SEROTONERGIC SYSTEM ; 5.1. Lipid Levels and Treatment Response to Antidepressants ; 5.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.1.2. Results. | |
| 505 | 8 | |a 5.2. Lipid Levels and Serotonin Receptor Gene Polymorphisms 5.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.2.2. Results ; 6. DISCUSSION ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; THE ROLE OF CIRCADIAN CLOCKSIN ABSORPTION AND METABOLISMOF DIETARY TRIGLYCERIDE ; ABSTRACT ; HIGHLIGHTS ; 1. INTRODUCTION ; 2. THE CIRCADIAN RHYTHM SYSTEM; 2.1. Central Oscillators ; 2.2. Peripheral Oscillators ; 3. MUTUAL PATHWAYS OF DIETARY TRIGLYCERIDE. | |
| 505 | 8 | |a 3.1. Characteristic of Diurnal Rhythm of Intestinal and LiverTriglyceride in Vivo, in the Perfused Liver, Hepatocytes, Enterocytes, and in Cultured Cells 3.2. Regulation of Triglyceride in the Catabolism Pathway ; 3.3. Regulation of Triglyceride in the Exogenous Pathway ; 3.4. Regulation of Triglyceride in the Endogenous Pathway ; 4. REGULATION OF TRIGLYCERIDE BY INSULIN, BILE ACID, AMPK, AND C-AMP SIGNALING ; 4.1. Insulin Signaling Pathway ; Forkhead-O Transcription Factors (FOXO1) ; PGC1Ü ; 4.2. Bile Acid Signaling ; 4.3. AMPK Signaling -role of Clock in Hepatic Steatosis Management. | |
| 505 | 8 | |a 4.4. c-AMP Signaling (CREB) 5. DIRECT AND INDIRECT MECHANISMS; 5.1. Food Intake -as an Output and Input System of CircadianClock System ; 5.2. Central Nervous System Effects on Plasma Triglyceridein Rodents ; 5.3. "Metabolic Sensing" Neurons: Fatty Acids, Leptin ; 5.4. Arginine Vasopressin (AVP) Receptor Couples Metabolism with Circadian Rhythm ; 5.5. Glucocorticoids -Crosstalk between Circadian Clock and Glucocorticoids in Regulation Triglyceride Absorption and Metabolis; 6. FUTURE PROSPECTS ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES. | |
| 520 | |a In this book, the authors discuss the chemical structure, biosynthesis and role in disease of triglycerides. Topics include lipid levels in neuropsychiatric disorders; the role of circadian clocks in the absorption and metabolism of dietary triglycerides; serum lipoprotein lipase mass as a novel biomarker of insulin sensitivity; and the effect of plasma lipids and APOE genotype on cognitive decline. | ||
| 650 | 0 | |a Triglycerides. |0 http://id.loc.gov/authorities/subjects/sh85137515 | |
| 650 | 0 | |a Triglycerides |x Physiological effect. | |
| 650 | 2 | |a Triglycerides | |
| 650 | 2 | |a Triglycerides |x physiology |0 https://id.nlm.nih.gov/mesh/D014280Q000502 | |
| 650 | 6 | |a Triglycérides. | |
| 650 | 6 | |a Triglycérides |x Effets physiologiques. | |
| 650 | 7 | |a MEDICAL |x Nutrition. |2 bisacsh | |
| 650 | 7 | |a Triglycerides |2 fast | |
| 700 | 1 | |a Araujo, Calista, |e editor. | |
| 700 | 1 | |a Perez, Demetrio, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Triglycerides. |d New York : Nova Biomedical, [2013] |z 9781624177279 |w (DLC) 2012955266 |
| 830 | 0 | |a Endocrinology research and clinical developments. |0 http://id.loc.gov/authorities/names/n2009181089 | |
| 830 | 0 | |a Biochemistry research trends series. |0 http://id.loc.gov/authorities/names/n2009180480 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=561599 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3020599 | ||
| 938 | |a ebrary |b EBRY |n ebr10678004 | ||
| 938 | |a EBSCOhost |b EBSC |n 561599 | ||
| 938 | |a YBP Library Services |b YANK |n 10404713 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn846915995 |
|---|---|
| _version_ | 1816882234389430273 |
| adam_text | |
| any_adam_object | |
| author2 | Araujo, Calista Perez, Demetrio |
| author2_role | edt edt |
| author2_variant | c a ca d p dp |
| author_facet | Araujo, Calista Perez, Demetrio |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QP752 |
| callnumber-raw | QP752.T74 |
| callnumber-search | QP752.T74 |
| callnumber-sort | QP 3752 T74 |
| callnumber-subject | QP - Physiology |
| collection | ZDB-4-EBA |
| contents | TRIGLYCERIDES ; TRIGLYCERIDES ; CONTENTS ; PREFACE ; LIPID LEVELS IN NEUROPSYCHIATRIC DISORDERS; ABSTRACT ; 1. LIPIDS AND THE CENTRAL NERVOUS SYSTEM ; 2. LIPIDS IN ALZHEIMER'S DISEASE ; 2.1. Subjects and Methods; Subjects ; Methods ; Statistical Analysis ; 2.2. Results ; 3. LIPIDS AND MOOD DISORDERS ; 3.1. Lipid Levels in Affective Disorders ; 3.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.1.2. Results ; 3.2. Lipid Levels in Psychotic Mania ; 3.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.2.2. Results. 4. LIPIDS AND SUICIDAL BEHAVIOR 4.1. Lipid Levels and Suicidal Behavior in Borderline Personality Disorder ; 4.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.1.2. Results ; 4.2. Lipid Levels and Suicidal Behavior in Psychotic Disorder ; 4.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.2.2. Results ; 5. LIPIDS AND SEROTONERGIC SYSTEM ; 5.1. Lipid Levels and Treatment Response to Antidepressants ; 5.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.1.2. Results. 5.2. Lipid Levels and Serotonin Receptor Gene Polymorphisms 5.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.2.2. Results ; 6. DISCUSSION ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; THE ROLE OF CIRCADIAN CLOCKSIN ABSORPTION AND METABOLISMOF DIETARY TRIGLYCERIDE ; ABSTRACT ; HIGHLIGHTS ; 1. INTRODUCTION ; 2. THE CIRCADIAN RHYTHM SYSTEM; 2.1. Central Oscillators ; 2.2. Peripheral Oscillators ; 3. MUTUAL PATHWAYS OF DIETARY TRIGLYCERIDE. 3.1. Characteristic of Diurnal Rhythm of Intestinal and LiverTriglyceride in Vivo, in the Perfused Liver, Hepatocytes, Enterocytes, and in Cultured Cells 3.2. Regulation of Triglyceride in the Catabolism Pathway ; 3.3. Regulation of Triglyceride in the Exogenous Pathway ; 3.4. Regulation of Triglyceride in the Endogenous Pathway ; 4. REGULATION OF TRIGLYCERIDE BY INSULIN, BILE ACID, AMPK, AND C-AMP SIGNALING ; 4.1. Insulin Signaling Pathway ; Forkhead-O Transcription Factors (FOXO1) ; PGC1Ü ; 4.2. Bile Acid Signaling ; 4.3. AMPK Signaling -role of Clock in Hepatic Steatosis Management. 4.4. c-AMP Signaling (CREB) 5. DIRECT AND INDIRECT MECHANISMS; 5.1. Food Intake -as an Output and Input System of CircadianClock System ; 5.2. Central Nervous System Effects on Plasma Triglyceridein Rodents ; 5.3. "Metabolic Sensing" Neurons: Fatty Acids, Leptin ; 5.4. Arginine Vasopressin (AVP) Receptor Couples Metabolism with Circadian Rhythm ; 5.5. Glucocorticoids -Crosstalk between Circadian Clock and Glucocorticoids in Regulation Triglyceride Absorption and Metabolis; 6. FUTURE PROSPECTS ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES. |
| ctrlnum | (OCoLC)846915995 |
| dewey-full | 612.397 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 612 - Human physiology |
| dewey-raw | 612.397 |
| dewey-search | 612.397 |
| dewey-sort | 3612.397 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05760cam a2200709 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn846915995</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">121205s2013 nyua ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2019713992</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DLC</subfield><subfield code="d">YDXCP</subfield><subfield code="d">COO</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCF</subfield><subfield code="d">VTS</subfield><subfield code="d">CEF</subfield><subfield code="d">AU@</subfield><subfield code="d">STF</subfield><subfield code="d">M8D</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">E7B</subfield><subfield code="d">CNSPO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB350009</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">016416269</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">847619635</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781624177286</subfield><subfield code="q">(ebook)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">162417728X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1624177271</subfield><subfield code="q">(hbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781624177279</subfield><subfield code="q">(hbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)846915995</subfield><subfield code="z">(OCoLC)847619635</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">QP752.T74</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QU 85</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">060000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">612.397</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Triglycerides :</subfield><subfield code="b">chemical structure, biosynthesis and role in disease /</subfield><subfield code="c">Calista Araujo and Demetrio Perez, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Biomedical,</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Endocrinology, research and clinical developments</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Biochemistry research trends</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">TRIGLYCERIDES ; TRIGLYCERIDES ; CONTENTS ; PREFACE ; LIPID LEVELS IN NEUROPSYCHIATRIC DISORDERS; ABSTRACT ; 1. LIPIDS AND THE CENTRAL NERVOUS SYSTEM ; 2. LIPIDS IN ALZHEIMER'S DISEASE ; 2.1. Subjects and Methods; Subjects ; Methods ; Statistical Analysis ; 2.2. Results ; 3. LIPIDS AND MOOD DISORDERS ; 3.1. Lipid Levels in Affective Disorders ; 3.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.1.2. Results ; 3.2. Lipid Levels in Psychotic Mania ; 3.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.2.2. Results.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4. LIPIDS AND SUICIDAL BEHAVIOR 4.1. Lipid Levels and Suicidal Behavior in Borderline Personality Disorder ; 4.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.1.2. Results ; 4.2. Lipid Levels and Suicidal Behavior in Psychotic Disorder ; 4.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.2.2. Results ; 5. LIPIDS AND SEROTONERGIC SYSTEM ; 5.1. Lipid Levels and Treatment Response to Antidepressants ; 5.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.1.2. Results.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5.2. Lipid Levels and Serotonin Receptor Gene Polymorphisms 5.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.2.2. Results ; 6. DISCUSSION ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; THE ROLE OF CIRCADIAN CLOCKSIN ABSORPTION AND METABOLISMOF DIETARY TRIGLYCERIDE ; ABSTRACT ; HIGHLIGHTS ; 1. INTRODUCTION ; 2. THE CIRCADIAN RHYTHM SYSTEM; 2.1. Central Oscillators ; 2.2. Peripheral Oscillators ; 3. MUTUAL PATHWAYS OF DIETARY TRIGLYCERIDE.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.1. Characteristic of Diurnal Rhythm of Intestinal and LiverTriglyceride in Vivo, in the Perfused Liver, Hepatocytes, Enterocytes, and in Cultured Cells 3.2. Regulation of Triglyceride in the Catabolism Pathway ; 3.3. Regulation of Triglyceride in the Exogenous Pathway ; 3.4. Regulation of Triglyceride in the Endogenous Pathway ; 4. REGULATION OF TRIGLYCERIDE BY INSULIN, BILE ACID, AMPK, AND C-AMP SIGNALING ; 4.1. Insulin Signaling Pathway ; Forkhead-O Transcription Factors (FOXO1) ; PGC1Ü ; 4.2. Bile Acid Signaling ; 4.3. AMPK Signaling -role of Clock in Hepatic Steatosis Management.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.4. c-AMP Signaling (CREB) 5. DIRECT AND INDIRECT MECHANISMS; 5.1. Food Intake -as an Output and Input System of CircadianClock System ; 5.2. Central Nervous System Effects on Plasma Triglyceridein Rodents ; 5.3. "Metabolic Sensing" Neurons: Fatty Acids, Leptin ; 5.4. Arginine Vasopressin (AVP) Receptor Couples Metabolism with Circadian Rhythm ; 5.5. Glucocorticoids -Crosstalk between Circadian Clock and Glucocorticoids in Regulation Triglyceride Absorption and Metabolis; 6. FUTURE PROSPECTS ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this book, the authors discuss the chemical structure, biosynthesis and role in disease of triglycerides. Topics include lipid levels in neuropsychiatric disorders; the role of circadian clocks in the absorption and metabolism of dietary triglycerides; serum lipoprotein lipase mass as a novel biomarker of insulin sensitivity; and the effect of plasma lipids and APOE genotype on cognitive decline.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Triglycerides.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85137515</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Triglycerides</subfield><subfield code="x">Physiological effect.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Triglycerides</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Triglycerides</subfield><subfield code="x">physiology</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014280Q000502</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Triglycérides.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Triglycérides</subfield><subfield code="x">Effets physiologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Nutrition.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Triglycerides</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Araujo, Calista,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perez, Demetrio,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Triglycerides.</subfield><subfield code="d">New York : Nova Biomedical, [2013]</subfield><subfield code="z">9781624177279</subfield><subfield code="w">(DLC) 2012955266</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Endocrinology research and clinical developments.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2009181089</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Biochemistry research trends series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2009180480</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=561599</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3020599</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10678004</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">561599</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">10404713</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn846915995 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:25:22Z |
| institution | BVB |
| isbn | 9781624177286 162417728X |
| language | English |
| lccn | 2019713992 |
| oclc_num | 846915995 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Nova Biomedical, |
| record_format | marc |
| series | Endocrinology research and clinical developments. Biochemistry research trends series. |
| series2 | Endocrinology, research and clinical developments Biochemistry research trends |
| spelling | Triglycerides : chemical structure, biosynthesis and role in disease / Calista Araujo and Demetrio Perez, editors. New York : Nova Biomedical, [2013] ©2013 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Endocrinology, research and clinical developments Biochemistry research trends Includes bibliographical references and index. Print version record. TRIGLYCERIDES ; TRIGLYCERIDES ; CONTENTS ; PREFACE ; LIPID LEVELS IN NEUROPSYCHIATRIC DISORDERS; ABSTRACT ; 1. LIPIDS AND THE CENTRAL NERVOUS SYSTEM ; 2. LIPIDS IN ALZHEIMER'S DISEASE ; 2.1. Subjects and Methods; Subjects ; Methods ; Statistical Analysis ; 2.2. Results ; 3. LIPIDS AND MOOD DISORDERS ; 3.1. Lipid Levels in Affective Disorders ; 3.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.1.2. Results ; 3.2. Lipid Levels in Psychotic Mania ; 3.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.2.2. Results. 4. LIPIDS AND SUICIDAL BEHAVIOR 4.1. Lipid Levels and Suicidal Behavior in Borderline Personality Disorder ; 4.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.1.2. Results ; 4.2. Lipid Levels and Suicidal Behavior in Psychotic Disorder ; 4.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.2.2. Results ; 5. LIPIDS AND SEROTONERGIC SYSTEM ; 5.1. Lipid Levels and Treatment Response to Antidepressants ; 5.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.1.2. Results. 5.2. Lipid Levels and Serotonin Receptor Gene Polymorphisms 5.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.2.2. Results ; 6. DISCUSSION ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; THE ROLE OF CIRCADIAN CLOCKSIN ABSORPTION AND METABOLISMOF DIETARY TRIGLYCERIDE ; ABSTRACT ; HIGHLIGHTS ; 1. INTRODUCTION ; 2. THE CIRCADIAN RHYTHM SYSTEM; 2.1. Central Oscillators ; 2.2. Peripheral Oscillators ; 3. MUTUAL PATHWAYS OF DIETARY TRIGLYCERIDE. 3.1. Characteristic of Diurnal Rhythm of Intestinal and LiverTriglyceride in Vivo, in the Perfused Liver, Hepatocytes, Enterocytes, and in Cultured Cells 3.2. Regulation of Triglyceride in the Catabolism Pathway ; 3.3. Regulation of Triglyceride in the Exogenous Pathway ; 3.4. Regulation of Triglyceride in the Endogenous Pathway ; 4. REGULATION OF TRIGLYCERIDE BY INSULIN, BILE ACID, AMPK, AND C-AMP SIGNALING ; 4.1. Insulin Signaling Pathway ; Forkhead-O Transcription Factors (FOXO1) ; PGC1Ü ; 4.2. Bile Acid Signaling ; 4.3. AMPK Signaling -role of Clock in Hepatic Steatosis Management. 4.4. c-AMP Signaling (CREB) 5. DIRECT AND INDIRECT MECHANISMS; 5.1. Food Intake -as an Output and Input System of CircadianClock System ; 5.2. Central Nervous System Effects on Plasma Triglyceridein Rodents ; 5.3. "Metabolic Sensing" Neurons: Fatty Acids, Leptin ; 5.4. Arginine Vasopressin (AVP) Receptor Couples Metabolism with Circadian Rhythm ; 5.5. Glucocorticoids -Crosstalk between Circadian Clock and Glucocorticoids in Regulation Triglyceride Absorption and Metabolis; 6. FUTURE PROSPECTS ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES. In this book, the authors discuss the chemical structure, biosynthesis and role in disease of triglycerides. Topics include lipid levels in neuropsychiatric disorders; the role of circadian clocks in the absorption and metabolism of dietary triglycerides; serum lipoprotein lipase mass as a novel biomarker of insulin sensitivity; and the effect of plasma lipids and APOE genotype on cognitive decline. Triglycerides. http://id.loc.gov/authorities/subjects/sh85137515 Triglycerides Physiological effect. Triglycerides Triglycerides physiology https://id.nlm.nih.gov/mesh/D014280Q000502 Triglycérides. Triglycérides Effets physiologiques. MEDICAL Nutrition. bisacsh Triglycerides fast Araujo, Calista, editor. Perez, Demetrio, editor. Print version: Triglycerides. New York : Nova Biomedical, [2013] 9781624177279 (DLC) 2012955266 Endocrinology research and clinical developments. http://id.loc.gov/authorities/names/n2009181089 Biochemistry research trends series. http://id.loc.gov/authorities/names/n2009180480 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=561599 Volltext |
| spellingShingle | Triglycerides : chemical structure, biosynthesis and role in disease / Endocrinology research and clinical developments. Biochemistry research trends series. TRIGLYCERIDES ; TRIGLYCERIDES ; CONTENTS ; PREFACE ; LIPID LEVELS IN NEUROPSYCHIATRIC DISORDERS; ABSTRACT ; 1. LIPIDS AND THE CENTRAL NERVOUS SYSTEM ; 2. LIPIDS IN ALZHEIMER'S DISEASE ; 2.1. Subjects and Methods; Subjects ; Methods ; Statistical Analysis ; 2.2. Results ; 3. LIPIDS AND MOOD DISORDERS ; 3.1. Lipid Levels in Affective Disorders ; 3.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.1.2. Results ; 3.2. Lipid Levels in Psychotic Mania ; 3.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 3.2.2. Results. 4. LIPIDS AND SUICIDAL BEHAVIOR 4.1. Lipid Levels and Suicidal Behavior in Borderline Personality Disorder ; 4.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.1.2. Results ; 4.2. Lipid Levels and Suicidal Behavior in Psychotic Disorder ; 4.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 4.2.2. Results ; 5. LIPIDS AND SEROTONERGIC SYSTEM ; 5.1. Lipid Levels and Treatment Response to Antidepressants ; 5.1.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.1.2. Results. 5.2. Lipid Levels and Serotonin Receptor Gene Polymorphisms 5.2.1. Subjects and Methods ; Subjects ; Methods ; Statistical Analysis ; 5.2.2. Results ; 6. DISCUSSION ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; THE ROLE OF CIRCADIAN CLOCKSIN ABSORPTION AND METABOLISMOF DIETARY TRIGLYCERIDE ; ABSTRACT ; HIGHLIGHTS ; 1. INTRODUCTION ; 2. THE CIRCADIAN RHYTHM SYSTEM; 2.1. Central Oscillators ; 2.2. Peripheral Oscillators ; 3. MUTUAL PATHWAYS OF DIETARY TRIGLYCERIDE. 3.1. Characteristic of Diurnal Rhythm of Intestinal and LiverTriglyceride in Vivo, in the Perfused Liver, Hepatocytes, Enterocytes, and in Cultured Cells 3.2. Regulation of Triglyceride in the Catabolism Pathway ; 3.3. Regulation of Triglyceride in the Exogenous Pathway ; 3.4. Regulation of Triglyceride in the Endogenous Pathway ; 4. REGULATION OF TRIGLYCERIDE BY INSULIN, BILE ACID, AMPK, AND C-AMP SIGNALING ; 4.1. Insulin Signaling Pathway ; Forkhead-O Transcription Factors (FOXO1) ; PGC1Ü ; 4.2. Bile Acid Signaling ; 4.3. AMPK Signaling -role of Clock in Hepatic Steatosis Management. 4.4. c-AMP Signaling (CREB) 5. DIRECT AND INDIRECT MECHANISMS; 5.1. Food Intake -as an Output and Input System of CircadianClock System ; 5.2. Central Nervous System Effects on Plasma Triglyceridein Rodents ; 5.3. "Metabolic Sensing" Neurons: Fatty Acids, Leptin ; 5.4. Arginine Vasopressin (AVP) Receptor Couples Metabolism with Circadian Rhythm ; 5.5. Glucocorticoids -Crosstalk between Circadian Clock and Glucocorticoids in Regulation Triglyceride Absorption and Metabolis; 6. FUTURE PROSPECTS ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES. Triglycerides. http://id.loc.gov/authorities/subjects/sh85137515 Triglycerides Physiological effect. Triglycerides Triglycerides physiology https://id.nlm.nih.gov/mesh/D014280Q000502 Triglycérides. Triglycérides Effets physiologiques. MEDICAL Nutrition. bisacsh Triglycerides fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85137515 https://id.nlm.nih.gov/mesh/D014280Q000502 |
| title | Triglycerides : chemical structure, biosynthesis and role in disease / |
| title_auth | Triglycerides : chemical structure, biosynthesis and role in disease / |
| title_exact_search | Triglycerides : chemical structure, biosynthesis and role in disease / |
| title_full | Triglycerides : chemical structure, biosynthesis and role in disease / Calista Araujo and Demetrio Perez, editors. |
| title_fullStr | Triglycerides : chemical structure, biosynthesis and role in disease / Calista Araujo and Demetrio Perez, editors. |
| title_full_unstemmed | Triglycerides : chemical structure, biosynthesis and role in disease / Calista Araujo and Demetrio Perez, editors. |
| title_short | Triglycerides : |
| title_sort | triglycerides chemical structure biosynthesis and role in disease |
| title_sub | chemical structure, biosynthesis and role in disease / |
| topic | Triglycerides. http://id.loc.gov/authorities/subjects/sh85137515 Triglycerides Physiological effect. Triglycerides Triglycerides physiology https://id.nlm.nih.gov/mesh/D014280Q000502 Triglycérides. Triglycérides Effets physiologiques. MEDICAL Nutrition. bisacsh Triglycerides fast |
| topic_facet | Triglycerides. Triglycerides Physiological effect. Triglycerides Triglycerides physiology Triglycérides. Triglycérides Effets physiologiques. MEDICAL Nutrition. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=561599 |
| work_keys_str_mv | AT araujocalista triglycerideschemicalstructurebiosynthesisandroleindisease AT perezdemetrio triglycerideschemicalstructurebiosynthesisandroleindisease |